Delivery Order SPE2DB22D1106-SPE2DB24FELK8
- Not listed
- This is a $1,645.62 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML and has a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense through...
- This is a $8,137.32 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of December 31, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999, which serves as a primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The award, valued at $1,058.60, has a period of performance through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,339.62 order is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The delivery order has a completion date of March 11, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor for DLA, holding an indefinite delivery contract (IDC) valued at up...
- This is a $3,713.76 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of the prescription drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is...
- This is a $16,776.40 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the supply of the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. No set-aside designation was used. The delivery order was issued under DLA's medical supplies and pharmaceutical support programs, with performance to take place...
- This is a $5,107.36 firm fixed-price delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a completion date of December 30, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and...
- This is a $2,304.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a performance period through November 14, 2024. This award is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a $1,130.17 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a completion date of May 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $3,373.35 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a performance period ending on January 15, 2025. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and there is no indication of any subcontractors. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FELK8Delivery Order
This is a $3,772.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The order does not have a set-aside designation. As a major pharmaceutical distribution company, Amerisourcebergen leverages its extensive supply chain to efficiently fulfill government medical product contracts for agencies like the DLA and Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 4/15/24 |